Loading
Life sciences · Journal article
International Journal of Analysis and Applications · October 26, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
In this work, we study the post-treatment dynamics of non-small-cell lung cancer through a nonlinear tumor–immune interaction model incorporating the residual effects of surgery and chemotherapy. Tumor cells, cytotoxic CD8\(^+\) T lymphocytes, and dendritic cells are described by a system of ordinary differential equations in which therapeutic interventions are embedded as persistent biological effects acting on both tumor and immune populations. This modeling approach focuses on long-term outcomes following treatment rather than the treatment process itself. The model is shown to be well posed through positivity and boundedness of solutions, ensuring biological feasibility. Three biologically meaningful equilibrium states are identified, corresponding to tumor eradication, immune failure with tumor persistence, and controlled chronic disease. Explicit local stability conditions for these equilibria are derived using linearization and the Routh–Hurwitz criteria, revealing the roles of tumor growth, immune effectiveness, and treatment-induced immune toxicity in shaping post-treatment outcomes. Numerical illustrations support the analytical results and demonstrate robust convergence toward the predicted equilibrium states. A sensitivity analysis highlights the trade-off between chemotherapy-induced tumor killing and immune suppression, emphasizing the importance of immune preservation for favorable long-term tumor control. Overall, the proposed framework provides a mathematically rigorous and biologically interpretable description of post-treatment cancer dynamics and offers qualitative insight into remission, relapse, and disease control following therapy.